Edwards Lifesciences (EW) Change in Acquisitions & Divestments (2009 - 2026)

Edwards Lifesciences' Change in Acquisitions & Divestments history runs 17 years deep, the most recent figure standing at $12.5 million for Q1 2026.

• On a quarterly basis, Change in Acquisitions & Divestments fell 29.38% year-over-year to $12.5 million in Q1 2026; TTM through Mar 2026 was $56.9 million, a 169.31% increase from a year earlier, with the FY2025 full-year figure at $62.1 million, up 8.0% from the prior year.
• Change in Acquisitions & Divestments advanced to $12.5 million in Q1 2026 per EW's latest filing, from $7.9 million in the prior quarter.
• Across five years, Change in Acquisitions & Divestments topped out at $566.1 million in Q2 2022 and bottomed at -$481.6 million in Q4 2024.
• The 5-year median for Change in Acquisitions & Divestments is $18.0 million (2022), against an average of $38.2 million.
• Across the five-year window, Change in Acquisitions & Divestments jumped 1515.25% in 2022 and slumped 200.76% in 2024, its largest moves.
• Year by year, Change in Acquisitions & Divestments stood at -$341.6 million in 2022, then retreated by 13.88% to -$389.0 million in 2023, then decreased by 23.8% to -$481.6 million in 2024, then surged by 101.64% to $7.9 million in 2025, then soared by 58.23% to $12.5 million in 2026.
• Per Business Quant, the three latest EW Change in Acquisitions & Divestments figures stand at $12.5 million (Q1 2026), $7.9 million (Q4 2025), and $22.2 million (Q3 2025).